Molecular analysis of chromosomal rearrangements in mammalian cells after φC31-mediated integration

Human Gene Therapy

Volumn 17, Issue 11, 2006, Pages 1077-1094

  Ehrhardt, Anja ^a,b   Engler, Jeffrey A ^c   Xu, Hui ^a   Cherry, Athena M ^a   Kay, Mark A ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MUNICH   (Germany)

^c UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; INTEGRASE; VIRUS ENZYME;

ANIMAL CELL; ARTICLE; ATTB GENE; BACTERIAL GENE; BACTERIOPHAGE; BACTERIOPHAGE PHI C31; CELL CLONE; CHROMOSOME 10; CHROMOSOME 12Q; CHROMOSOME 19Q; CHROMOSOME ANALYSIS; CHROMOSOME MUTATION; CHROMOSOME REARRANGEMENT; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; DNA FLANKING REGION; DNA INTEGRATION; EPISOME; GENE INSERTION; GENE INSERTION SEQUENCE; GENETIC ANALYSIS; GENETIC MANIPULATION; GENETIC RECOMBINATION; GENOME ANALYSIS; GENOTYPE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO CULTURE; MAMMAL CELL; MOUSE; NONHUMAN; POLYMERASE CHAIN REACTION; REGULATORY DNA SEQUENCE; SITE DIRECTED MUTAGENESIS; SOMATIC GENE THERAPY; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRUS DNA CELL DNA INTERACTION;

ANIMALS; BASE SEQUENCE; CELL LINE; HUMANS; INTEGRASES; KARYOTYPING; MICE; MOLECULAR SEQUENCE DATA; PHYSICAL CHROMOSOME MAPPING; POLYMERASE CHAIN REACTION; RECOMBINATION, GENETIC; TRANSLOCATION, GENETIC; VIRUS INTEGRATION;

MAMMALIA; STREPTOMYCES;

EID: 33750997895     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2006.17.1077     Document Type: Article

References (22)

1. BARCH, M.J., and KNUTSEN, T. (1997). The AGT Cytogenetics Laboratory Manual (Lippincott-Raven, New York) Vol. XIII. p. 666.
2. BERTONI, C., JARRAHIAN, S., WHEELER, T.M., LI, Y., OLIVARES, E.C., CALOS, M.P., and RANDO, T.A. (2006). Enhancement of plasmid-mediated gene therapy for muscular dystrophy by directed plasmid integration. Proc. Natl. Acad. Sci. U.S.A. 103, 419-424.
3. CHALBERG, T.W., PORTLOCK, J.L., OLIVARES, E.C., THYAGARAJAN, B., KIRBY, P.J., HILLMAN, R.T., HOELTERS, I., and CALOS, M.P. (2006). Integration specificity of phage φC31 integrase in the human genome. J. Mol. Biol. 357, 28-48.
4. EHRHARDT, A., XU, H., HUANG, Z., ENGLER, J.A., and KAY, M.A. (2005). A direct comparison of two nonviral gene therapy vectors for somatic integration: In vivo evaluation of the bacteriophage integrase φC31 and the Sleeping Beauty tvansposase. Mol. Ther. 11, 695-706.
5. HELD, P.K., OLIVARES, E.C., AGUILAR, C.P., FINEGOLD, M., CALOS, M.P., and GROMPE, M. (2005). In vivo correction of murine hereditary tyrosinemia type I by φC31 integrase-mediated gene delivery. Mol. Ther. 11, 399-408.
6. ISHIKAWA, Y., TANAKA, N., MURAKAMI, K., UCHIYAMA, T., KUMAKI, S., TSUCHIYA, S., KUGOH, H., OSHIMURA, M., CALOS, M.P., and SUGAMURA, K. (2006). Phage φC31 integrase-mediated genomic integration of the common cytokine receptor γ chain in human T-cell lines. J. Gene Med. 8, 646-653.
7. LIU, J., JEPPESEN, I., NIELSEN, K., and JENSEN, T.G. (2006). φC31 integrate induces chromosomal aberrations in primary human fibroblasts. Gene Ther. 13, 1188-1190.
8. MILLER, D.G., RUTLEDGE, E.A., and RUSSELL, D.W. (2002). Chromosomal effects of adeno-associated virus vector integration. Nat. Genet. 30, 147-148.
9. MOHR, B., und ILLMER, T. (2005). Structural chromosomal aberrations in the colon cancer cell line HCT 116: Results of investigations based on spectral karyotyping. Cytogenet. Genome Res. 108, 359-361.
10. NAKAI, H., MONTINI, E., FUESS, S., STORM, T.A., GROMPE, M., and KAY, M.A. (2003). AAV scrotype 2 vectors preferentially integrate into active genes in mice. Nat. Genet. 34, 297-302.
11. NAKAI, H., WU, X., FUESS, S., STORM, T.A., MUNROE, D., MONTINI, E., BURGESS, S.M., GROMPE, M., and KAY, M.A. (2005). Large-scale molecular characterization of adeno-associated virus vector integration in mouse liver. J. Virol. 79, 3606-3614.
12. OLIVARES, E.C., HOLLIS, R.P., CHALBERG, T.W., MEUSE, L., KAY, M.A., and CALOS, M.P. (2002). Site-specific genomic integration produces therapeutic factor IX levels in mice. Nat. Biotechnol. 20, 1124-1128.
13. ORTIZ-URDA, S., THYAGARAJAN, B., KEENE, D.R., LIN, Q., FANG, M., CALOS, M.P., and KHAVARI, P.A. (2002). Stable non-viral genetic correction of inherited human skin disease. Nat. Med. 8, 1166-1170.
14. ORTIZ-URDA, S., THYAGARAJAN, B., KEENE, D.R., LIN, Q., CALOS, M.P., and KHAVARI, P.A. (2003). φC31 integrase-mediated nonviral genetic correction of junctional epidermolysis bullosa. Hum. Gene Ther. 14, 923-928.
15. SCHMIDT, E.E., TAYLOR, D.S., PRIGGE, J.R., BARNETT, S., and CAPECCHI, M.R. (2000). Illegitimate Cre-dependent chromosome rearrangements in transgenic mouse spermatids. Proc. Natl. Acad. Sci. U.S.A. 97, 13702-13707.
16. SCHRODER. A.R., SHINN, P., CHEN, H., BERRY, C., ECKER, J.R., and BUSHMAN, F. (2002). HIV-1 integration in the human genome favors active genes and local hotspots. Cell 110, 521-529.
17. SEABRIGHT, M. (1971). A rapid handing technique for human chromosomes. Lancet 2, 971-972.
18. THORPE, H.M., and SMITH, M.C. (1998). In vitro site-specific integration of bacteriophage DNA catalyzed by a recombinase of the resolvase/invertase family. Proc. Natl. Acad. Sci. U.S.A. 95, 5505-5510.
19. THYAGARAJAN, B., OLIVARES, E.C., HOLLIS, R.P., GINSBURG, D.S., and CALOS, M.P. (2001). Site-specific genomic integration in mammalian cells mediated by phage φC31 integrase. Mol. Cell. Biol. 21, 3926-3934.
20. WU, X., and BURGESS.,S.M. (2004). Integration target site selection for retroviruses and transposable elements. Cell. Mol. Life Sci. 61, 2588-2596.
21. YANT, S.R., WU, X., HUANG, Y., GARRISON, B., BURGESS, S.M., and KAY, M.A. (2005). High-resolution genome-wide mapping of transposon integration in mammals. Mol. Cell. Biol. 25, 2085-2094.
22. YU, Y., and BRADLEY, A. (2001). Engineering chromosomal rearrangements in mice. Nat. Rev. Genet. 2, 780-790.